RYZB

RayzeBio, Inc. Common Stock
RYZB

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

RYZB was delisted on the 23rd of February, 2024.

Back to rankings
 

About: RayzeBio inc is a company operating as vertically integrated radiopharmaceutical therapeutics company. The main objective of the company is defeating cancer with radiopharmaceutical medicines. It has a created a pipeline of multiple drug candidates, in therapeutic areas with significant market opportunities. They have a portfolio of potential RPT drug and development candidates that includes late-stage clinical programs, development programs and discovery programs.

Employees: 88

Healthcare Drug Manufacturers - General
Price charts implemented using Lightweight Charts™